Market Overview:
The global antibody production services market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for therapeutic antibodies, rising prevalence of chronic diseases, and growing investments in R&D by biopharmaceutical companies. The global antibody production services market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into IgM antibodies, IgG antibodies, IgA antibodies, and other types of antibodies. The IgG antibody segment is expected to account for the largest share of the global antibody production services market in 2018. This can be attributed to factors such as rising demand for monoclonal IgG antibodies for therapeutic applications and increasing number of clinical trials using monoclonal IgG antibodies worldwide. On the basis of application,the global antibody production services market is divided into therapeutic applications (such as cancer therapy and autoimmune diseases), research applications (such as drug discovery & development),and diagnostic applications (such as ELISA kits).
Product Definition:
Antibody production services refers to the process of producing antibodies for therapeutic or research purposes. The importance of antibody production services lies in the fact that they can be used to produce large quantities of a specific antibody quickly and efficiently. Additionally, by using recombinant DNA technology, it is possible to create custom antibodies that are designed to target a specific antigen.
IgM:
IgM is the first type of antibody produced by B cells and T cells. It is also known as immunoglobulin M. The primary function of IgM antibodies in the human body is to enable the immune system to recognize and attack bacteria, viruses, and other foreign substances that cause infections.
IgG:
IgG is the first type of antibody produced by B cells and plasma cells in response to an antigen. It is also known as immunoglobulin G (IgG). IgG antibodies are the most common antibodies found in humans, with more than 80% of human population producing them. They are usually involved in protection against various infectious diseases and some autoimmune diseases.
The global Antibody Production Services market size was valued at USD 1,849 million in 2016.
Application Insights:
On the basis of application, the global antibody production services market is segmented into therapeutic, research and diagnostic. The therapeutic applications dominated the overall market in terms of revenue share in 2017. This can be attributed to increasing incidence of infectious diseases that require rapid response and ongoing monitoring for their management. Moreover, an increase in cancer cases has created a need for rapid detection methods that can help doctors make better decisions regarding treatment plans and medication doses. This factor is anticipated to fuel demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturing facilities coupled with high expenditure on R&D by pharmaceutical companies is one of the major factors contributing to its largest share. In addition, increasing prevalence of chronic diseases such as cancer and diabetes is expected to drive demand for ABPS during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising healthcare spending by governments and private players coupled with growing awareness regarding disease diagnosis & treatment options in emerging countries such as China, India, South Korea & Japan. Moreover, an increase in disposable income levels will also contribute towards regional market development during this timeframe.
The European region accounted for a significant revenue share in 2017 due to increased focus on research activities pertaining antibody-based therapeutics.
Growth Factors:
- Increasing demand for monoclonal antibodies for therapeutic and diagnostic applications
- Growing prevalence of cancer and other chronic diseases
- Rising investments in biotechnology and pharmaceutical industries
- Proliferation of contract research organizations (CROs) and antibody production services providers
- Technological advancements in antibody production platforms
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibody Production Services Market Research Report
By Type
IgM, IgG, IgA, Other
By Application
Therapeutic, Research, Diagnostic
By Companies
Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Antibody Production Services Market Report Segments:
The global Antibody Production Services market is segmented on the basis of:
Types
IgM, IgG, IgA, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Therapeutic, Research, Diagnostic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Johnson & Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
Highlights of The Antibody Production Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- IgM
- IgG
- IgA
- Other
- By Application:
- Therapeutic
- Research
- Diagnostic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibody Production Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibody production services are a type of laboratory service that helps to create antibodies for medical testing and research. These services can help to speed up the process of creating specific antibodies, which can be used in medical tests and research.
Some of the key players operating in the antibody production services market are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics.
The antibody production services market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibody Production Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibody Production Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibody Production Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibody Production Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibody Production Services Market Size & Forecast, 2018-2028
4.5.1 Antibody Production Services Market Size and Y-o-Y Growth
4.5.2 Antibody Production Services Market Absolute $ Opportunity
Chapter 5 Global Antibody Production Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antibody Production Services Market Size Forecast by Type
5.2.1 IgM
5.2.2 IgG
5.2.3 IgA
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antibody Production Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antibody Production Services Market Size Forecast by Applications
6.2.1 Therapeutic
6.2.2 Research
6.2.3 Diagnostic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antibody Production Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antibody Production Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antibody Production Services Analysis and Forecast
9.1 Introduction
9.2 North America Antibody Production Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antibody Production Services Market Size Forecast by Type
9.6.1 IgM
9.6.2 IgG
9.6.3 IgA
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antibody Production Services Market Size Forecast by Applications
9.10.1 Therapeutic
9.10.2 Research
9.10.3 Diagnostic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antibody Production Services Analysis and Forecast
10.1 Introduction
10.2 Europe Antibody Production Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antibody Production Services Market Size Forecast by Type
10.6.1 IgM
10.6.2 IgG
10.6.3 IgA
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antibody Production Services Market Size Forecast by Applications
10.10.1 Therapeutic
10.10.2 Research
10.10.3 Diagnostic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antibody Production Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antibody Production Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antibody Production Services Market Size Forecast by Type
11.6.1 IgM
11.6.2 IgG
11.6.3 IgA
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antibody Production Services Market Size Forecast by Applications
11.10.1 Therapeutic
11.10.2 Research
11.10.3 Diagnostic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antibody Production Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Antibody Production Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antibody Production Services Market Size Forecast by Type
12.6.1 IgM
12.6.2 IgG
12.6.3 IgA
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antibody Production Services Market Size Forecast by Applications
12.10.1 Therapeutic
12.10.2 Research
12.10.3 Diagnostic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antibody Production Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antibody Production Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antibody Production Services Market Size Forecast by Type
13.6.1 IgM
13.6.2 IgG
13.6.3 IgA
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antibody Production Services Market Size Forecast by Applications
13.10.1 Therapeutic
13.10.2 Research
13.10.3 Diagnostic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antibody Production Services Market: Competitive Dashboard
14.2 Global Antibody Production Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Johnson & Johnson
14.3.3 Merck
14.3.4 Novartis
14.3.5 AbbVie
14.3.6 Amgen
14.3.7 Pfizer
14.3.8 Bayer
14.3.9 Lilly
14.3.10 Bristol-Myers Squibb
14.3.11 GlaxoSmithKline
14.3.12 Biogen
14.3.13 AstraZeneca
14.3.14 Sanofi
14.3.15 Alexion Pharmaceuticals
14.3.16 Seattle Genetics
